Global Primary Cells Market – Industry Trends and Forecast to 2029

Global Primary Cells Market, By Type (Human Primary Cells, Animal Primary Cells, Others), Origin (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal and Muscle Cells Dermatocytes, Other Primary Cells), End User (Life Science Research Companies, Research Institutes) – Industry Trends and Forecast to 2029.

 Primary Cells Market Analysis and Size

The primary cell culture market is experiencing growth owing to the growing geriatric population, growing cases of chronic diseases, and advancements in research and development. The pharmaceutical market worldwide is attracting significant investments in advanced drug development and testing.

Data Bridge Market Research analyses that the primary cells market which was USD 1.24 billion in 2021, is expected to reach USD 2.92 billion by 2029, at a CAGR of 11.30% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Primary Cells Market Scope and Segmentation      

Market Definition

Primary cells refer to cells taken directly from living tissues of animals or humans and are then processed to establish them for use in appropriate cell therapies. Primary cells are widely used in various applications, including 3D cell culture, virology, cancer research, stem cell therapy, and tissue replacement. Researchers are increasingly using the 3D cell culture product to study cell biology and biochemistry, drug effects, cell signaling, and cell-pathogen interactions. The pharmaceutical industry uses the product to investigate drug cytotoxicity, produce biomolecules, and develop vaccines. The use of primary cells eliminates the need for animal models in vaccine development. Viruses can be detected and isolated to determine the mode of infection using primary cells.

Global Primary Cells Market Dynamics

Drivers

• Robust Investments into Research and Development (R&D)

Significant investments in R&D activities are rapidly driving the global market for primary cells to develop effective therapies in which primary cells can be used to treat various immunodeficiency disorders. Because of the growth of the biotechnology and biopharmaceutical industries, medical researchers are constantly working on using primary cells from animal or human tissue to treat malignant cancers. Furthermore, the use of patient-derived specimens in innovative preclinical technologies, such as 3D cell cultures, is driving the growth of the primary cell market. Furthermore, the use of human primary cells is increasingly becoming a preferred choice for studying the effects of cancer cells on the human body without using animal cells.

• Rising Cases of Cancers

The consistent growth in the global market for primary cells can be linked to the increasing occurrence of cancers around the world. Primary cells are used for cancer cell discovery and drug screening due to their superiority over cell lines, which is fuelling market growth. Furthermore, primary cells are used in extensive research activities to develop relevant therapies and techniques, such as cell therapies and regenerative therapies, to treat cancer patients; because cancer is recognized as the leading cause of death worldwide, governments and private institutes all over the world are rapidly investing in advanced healthcare technologies for effective cancer treatment, providing impetus to the primary cell market growth.

Opportunities

• Drug Screening and Toxicity Testing

To investigate the cytotoxicity of new drugs, primary cell cultures are used. It is useful for industrial-scale synthesis or production of a wide range of biomolecules. This is especially helpful in the pharmaceutical industry. Several research projects on cell-based therapeutic products based on primary cells are currently being developed. Primary culture is used instead of animal models to test the effects of new drugs, cosmetics, and chemicals. They are also used to calculate the maximum allowable dosage of new drugs. These are some of the factors expected to propel the market's growth.

Restraints/Challenges

• Concerns Regarding Primary Cell Culture Contamination

Cell contamination is one of the major problems in cell culture laboratories. Using contaminated cells endangers physiology, leads to incorrect results, and causes loss of unique cell lines.

This primary cells market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the primary cells market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Primary Cells Market

According to the WHO, 70 vaccine under development and 3 are already in human trials. The pandemic's economic and social burden has prompted global government bodies to increase support for vaccine development, which has led to increased adoption rates of primary cells for COVID-19 research.

Recent developments

• In March 2021, Axol Bioscience Ltd., a global leader in the market for primary cells, recently announced a merger with Censo Biotechnologies. The merged company is focused on providing product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets.

Global Primary Cells Market Scope

The primary cells market is segmented on the basis of type, origin, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Animal Primary Cells
• Human Primary Cells
• Others

Origin

• Dermatocytes
• Gastrointestinal Cells
• Heart Cells
• Hematopoietic Cells
• Hepatocytes
• Cryopreserved hepatocytes
•  Fresh hepatocytes
• Lung Cells
• Musculoskeletal Cells
• Renal Cells
• Others

End User

• Life Science Research Companies
• Research Institutes

Primary Cells Market Regional Analysis/Insights

The primary cells market is analyzed and market size insights and trends are provided by country, type, origin, and end user as referenced above.

The countries covered in the primary cells market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the primary cells market owing to the growing government funding in research, rising prevalence of cancer in the region and technological advancements.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising per capita health spending and rising geriatric population base.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The primary cells market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for primary cells market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the primary cells market. The data is available for historic period 2010-2020.

Competitive Landscape and Primary Cells Market Share Analysis

The primary cells market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to primary cells market.

Some of the major players operating in the primary cells market are:

• Thermo Fisher Scientific Inc (U.S.)
• Merck Group (Germany)
• Lonza (Switzerland)
• Cell Biologics, Inc. (U.S.)
• PromoCell - Human Centered Science (Germany)
• ZenBio, Inc. (U.S.)
• STEMCELL Technologies Inc (Canada)
• AllCells (U.S.)
• ATCC (U.S.)
• Axol Bioscience (U.K.)
• ReachBio Research Labs (U.S.)
• Charles River Laboratories (U.S.)
• Creative Bioarray (U.S.)
• PELOBIOTECH GmbH (Germany)
• Sigma-Aldrich Co. (U.S.)

Research Methodology: Global Primary Cells Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report. 

SKU-56543